Publications
59
Citations
2,853
Est. group size
—
Recurring co-author estimate
Active years
14
Publishing since 2012
Sara Sáez-Atiénzar studies the genetic and molecular basis of neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS), Parkinson's disease, and related conditions like frontotemporal dementia and dementia with Lewy bodies. Her work combines large-scale genomic and epigenetic (DNA methylation) data analysis with cell biology approaches to identify disease risk factors, biomarkers, and potential drug repurposing strategies. This research is aimed at understanding disease mechanisms and finding new diagnostic or therapeutic leads for patients with these brain and motor neuron disorders.
Publication output rose to a peak in 2020 and has since fluctuated at a lower but steady pace, averaging under 4 papers per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis
Nature Medicine · 2025
- Genomic Analysis Identifies Risk Factors in Restless Legs Syndrome
Annals of Neurology · 2024
- Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data
Cell Genomics · 2024
- Differential methylation analysis in neuropathologically confirmed dementia with Lewy bodies
Communications Biology · 2024
- Characterization of DNA methylation in PBMCs and donor-matched iPSCs shows methylation is reset during stem cell reprogramming
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Mechanism-Free Repurposing of Drugs For C9orf72-related ALS/FTD Using Large-Scale Genomic Data
SSRN Electronic Journal · 2024
- Mechanism-Free Repurposing of Drugs For C9orf72-Related ALS/FTD Using Large-Scale Genomic Data
SSRN Electronic Journal · 2024
- Cumulative Genetic Score and <i>C9orf72</i> Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies
Neurology Genetics · 2023
- Cumulative Genetic Score and C9orf72 Repeat Status Independently Contribute to Amyotrophic Lateral Sclerosis Risk in 2 Case-Control Studies
Neurology Genetics · 2023
- Genomic analysis identifies risk factors in restless legs syndrome
medRxiv · 2023
- ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function
Cell Reports · 2022
- Reply to Zhu et al.: Implications of <i>CHRNB1</i> and <i>ERBB2</i> in the pathobiology of myasthenia gravis
Proceedings of the National Academy of Sciences · 2022
- Cumulative genetic risk and <i>C9orf72</i> repeat status independently associate with ALS status in two case-control studies
medRxiv · 2022
- Differential Methylation Analysis in Neuropathologically Confirmed Dementia with Lewy Bodies
SSRN Electronic Journal · 2022
- Genetic analysis of amyotrophic lateral sclerosis identifies contributing pathways and cell types
Science Advances · 2021
- bioRxiv (Cold Spring Harbor Laboratory)×7
- Movement Disorders×5
- Cell Reports×4
- SSRN Electronic Journal×3
- Science Advances×2
- Aswathy Chandran
Medicine · Purdue University West Lafayette
- Victor S. Van Laar
Medicine · The Ohio State University
- Quyen Q. Hoang
Medicine · Indiana University
- Allison J. Schaser
Medicine · Purdue University West Lafayette
- Aristide Merola
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile